Vouchers for Future Kidney Transplants to Overcome 'Chronological Incompatibility' Between Living Donors and Recipients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28333861)

Published in Transplantation on March 22, 2017

Authors

Jeffrey L Veale1, Alexander M Capron, Nima Nassiri, Gabriel Danovitch, H Albin Gritsch, Amy Waterman, Joseph Del Pizzo, Jim C Hu, Marek Pycia, Suzanne McGuire, Marian Charlton, Sandip Kapur

Author Affiliations

1: 1 David Geffen School of Medicine at UCLA, Los Angeles, CA. 2 Gould School of Law, USC, Los Angeles, CA. 3 Keck School of Medicine, USC, Los Angeles, CA. 4 New York-Presbyterian Weill Cornell Medical Center, New York, CA. 5 Department of Economics, UCLA, Los Angeles, CA.

Articles by these authors

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61

Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60

Attitudes Toward Risk and Informed Consent for Research on Medical Practices: A Cross-sectional Survey. Ann Intern Med (2015) 3.71

The circulatory-respiratory determination of death in organ donation. Crit Care Med (2010) 3.02

Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol (2012) 2.94

Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 2.79

Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. J Urol (2010) 2.77

Economic costs of overactive bladder in the United States. Urology (2009) 2.68

Surrogate consent for living related organ donation. JAMA (2004) 2.57

Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39

Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol (2012) 2.37

Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31

Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology (2011) 2.24

Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24

Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22

Sirolimus-associated pulmonary toxicity. Transplantation (2004) 2.15

Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12

Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. Transplantation (2014) 2.11

Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol (2011) 2.09

Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. J Urol (2011) 2.05

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04

Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol (2012) 1.86

Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy. Urology (2010) 1.83

Informed consent in catastrophic disease research and treatment. Univ PA Law Rev (1974) 1.78

The OHRP and SUPPORT. N Engl J Med (2013) 1.78

Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78

Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol (2011) 1.76

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73

How should ethics be incorporated into public health policy and practice? Bull World Health Organ (2007) 1.70

International guideline development for the determination of death. Intensive Care Med (2014) 1.68

Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology (2013) 1.63

Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes. Urology (2011) 1.62

Deceased-donor kidney transplantation: improvement in long-term survival. Nephrol Dial Transplant (2010) 1.60

Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2010) 1.58

Trends in the care of radical prostatectomy in the United States from 2003 to 2006. BJU Int (2010) 1.57

Chronic nerve compression alters Schwann cell myelin architecture in a murine model. Muscle Nerve (2012) 1.53

Effect of ketorolac on renal function after donor nephrectomy. Urology (2002) 1.52

Living donor kidney transplantation in the United States--looking back, looking forward. Am J Kidney Dis (2011) 1.52

Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48

A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol (2013) 1.48

Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol (2003) 1.47

Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol (2012) 1.45

Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization. J Urol (2010) 1.45

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. Int J Radiat Oncol Biol Phys (2010) 1.44

Is right-sided laparoendoscopic single-site donor nephrectomy feasible? Urology (2011) 1.43

Optimizing HLA matching in a highly sensitized pediatric patient using ABO-incompatible and paired exchange kidney transplantation. Pediatr Nephrol (2015) 1.42

Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer (2014) 1.41

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA (2012) 1.41

Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. Transplantation (2002) 1.39

Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. J Sex Med (2014) 1.39

Successful transplantation of single kidneys from pediatric donors weighing less than or equal to 10 kg into standard weight adult recipients. Transplantation (2010) 1.39

Randomized controlled trial of barbed polyglyconate versus polyglactin suture for robot-assisted laparoscopic prostatectomy anastomosis: technique and outcomes. Eur Urol (2010) 1.38

Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology (2003) 1.38

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation (2008) 1.35

Promotion of altruistic donation. Transplantation (2009) 1.33

Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol (2010) 1.29

Utility of 16-MDCT angiography for comprehensive preoperative vascular evaluation of laparoscopic renal donors. AJR Am J Roentgenol (2006) 1.18

Reporting and disclosing medical errors: pediatricians' attitudes and behaviors. Arch Pediatr Adolesc Med (2007) 1.17

Overuse of imaging for staging low risk prostate cancer. J Urol (2011) 1.14

Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14

Time for a boycott of Chinese science and medicine pertaining to organ transplantation. Lancet (2011) 1.12

CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy. Cancer (2009) 1.03

Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation (2013) 1.03

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int (2011) 1.03

Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation (2010) 1.03

Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2009) 1.03

Overcoming the learning curve for robotic-assisted laparoscopic radical prostatectomy. Urol Clin North Am (2010) 1.03

Factors influencing organ donation decisions by African Americans: a review of the literature. Med Care Res Rev (2007) 1.02

Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med (2010) 1.02

Kidney paired donation in the presence of donor-specific antibodies. Kidney Int (2013) 1.01

A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant (2005) 1.00

Surgically relevant normal and variant renal parenchymal and vascular anatomy in preoperative 16-MDCT evaluation of potential laparoscopic renal donors. AJR Am J Roentgenol (2007) 1.00

Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. Int J Radiat Oncol Biol Phys (2011) 1.00

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol (2012) 0.98

Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol (2011) 0.98

A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97

Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer (2011) 0.97

Intrarenal color duplex ultrasonography: a window to vascular complications of renal transplants. J Ultrasound Med (2007) 0.97

Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96

Analysis of failure in living donor liver transplantation: differential outcomes in children and adults. World J Surg (2003) 0.95

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation (2008) 0.95

Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. Arthritis Rheum (2009) 0.94

Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol (2009) 0.93

Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation (2005) 0.92

Population-based determinants of radical prostatectomy surgical margin positivity. BJU Int (2010) 0.91

Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int (2009) 0.91

The current status of robotic oncologic surgery. CA Cancer J Clin (2012) 0.90

Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90

Long-term comparative outcomes between 2 common ureteroneocystostomy techniques for renal transplantation. J Urol (2007) 0.90